… Teh has received speaker's fees (less than $10,000) from … Teh has received speaker's
fees (less than $10,000) from … Teh has received speaker's fees (less than $10,000) from …

Objectives. To examine SLEDAI-2000 cut-off scores for definition of active SLE and to determine
the sensitivity to change of SLEDAI-2000 for the assessment of SLE disease activity and …

Objective. To develop an additive numerical scoring scheme for the BILAG-2004 index.
Methods. SLE patients were recruited into this multi-centre cross-sectional study. At every …

Objective To determine the construct and criterion validity of the British Isles Lupus
Assessment Group 2004 (BILAG‐2004) index for assessing disease activity in systemic lupus …

Objective. To determine if the BILAG-2004 index is sensitive to change for assessment of
SLE disease activity. Methods. This was a prospective multi-centre longitudinal study of SLE …

Background In a prospective observational study, we investigated whether patients with
active systemic lupus erythematosus (SLE) had higher indices of endothelial damage and …

Objectives To describe the baseline characteristics of SLE patients requiring biologic therapy
in the UK and to explore short term efficacy and infection rates associated with rituximab (…

Objective. To determine the relationship between serum vitamin D and markers of subclinical
cardiovascular disease (CVD) in patients with SLE. Methods. We recruited SLE patients (≥…

Objective To test the interrater reliability of the revised British Isles Lupus Assessment Group
2004 (BILAG‐2004) index for the assessment of systemic lupus erythematosus (SLE) activity…

Objective. Accelerated atherosclerosis and premature coronary heart disease (CHD) are
recognized complications of systemic lupus erythematosus (SLE), but the exact etiology …